Company Filing History:
2 out of 5,081 
2 out of 4 
1 out of 870 
Years Active: 2010-2013
Title: **The Innovative Contributions of Saliha Azebi in Coronavirus Research**
Introduction
Saliha Azebi, an esteemed inventor based in Vitry-sur-Seine, France, has made significant strides in the field of virology. With a focus on advancements related to the severe acute respiratory syndrome (SARS)-associated coronavirus, her work has the potential to impact global public health.
Latest Patents
Saliha Azebi holds two noteworthy patents that highlight her vital contributions to coronavirus research. The latest patent, titled "Strain of SARS-associated coronavirus and applications thereof," focuses on a novel strain of the SARS-associated coronavirus, which was identified from a sample collected in Hanoi, Vietnam. This invention includes nucleic acid molecules derived from the virus's genome, specifically relating to protein N, along with its numerous applications as diagnostic reagents and potential vaccine components. The patent bears the reference number 031589.
Career Highlights
Throughout her career, Saliha Azebi has been associated with prestigious institutions, including the Centre National De La Recherche Scientifique and Université Paris 7. These affiliations illustrate her commitment to rigorous scientific research and development, emphasizing her role in advancing our understanding of infectious diseases.
Collaborations
Working alongside prominent colleagues such as Sylvie Van Der Werf and Nicolas Escriou, Saliha Azebi has been part of a dynamic research environment that fosters innovation. These collaborations have enabled the sharing of knowledge and resources, further enhancing the impact of her work in addressing viral outbreaks.
Conclusion
Saliha Azebi's contributions to the field of coronavirus research through her patents and collaborations underline the importance of innovation in healthcare. Her dedication to developing practical applications for her discoveries positions her as a leading figure in the ongoing fight against infectious diseases, particularly in the context of global health challenges.